Wpg Advisers, LLC Ligand Pharmaceuticals Inc Transaction History
Wpg Advisers, LLC
- $107 Billion
- Q1 2025
A detailed history of Wpg Advisers, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Wpg Advisers, LLC holds 15 shares of LGND stock, worth $1,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$1,595
Previous $1.61 Million
1.87%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$305 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$219 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$109 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$96.4 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$79.2 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.8B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...